You have 9 free searches left this month | for more free features.

CSR1

Showing 1 - 25 of 9,168

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy Participants Trial in Lincoln (AB521)

Recruiting
  • Healthy Participants
  • Lincoln, Nebraska
    Celerion, Inc.
Aug 22, 2023

Cancer Trial (AB801, Placebo)

Not yet recruiting
  • Cancer
  • (no location specified)
Aug 15, 2023

Hypophosphatasia Trial (methotrexate, rituximab, bortezomib)

Not yet recruiting
  • Hypophosphatasia
  • (no location specified)
Aug 23, 2023

OSA Trial in France (New telemonitoring approach using 2 connected devices : Scanwatch connected watch + Asten&masanté

Not yet recruiting
  • OSA
  • New telemonitoring approach using 2 connected devices : Scanwatch connected watch + Asten&masanté application
  • Angers, France
  • +8 more
Jul 21, 2023

Advanced Cancer Trial (AB801, Zimberelimab, Docetaxel)

Not yet recruiting
  • Advanced Cancer
  • (no location specified)
Nov 1, 2023

Hepatocellular Carcinoma (HCC) Trial in Taiwan, United States (IA therapy of HCC with CSR02-Fab-TF)

Recruiting
  • Hepatocellular Carcinoma (HCC)
  • IA therapy of HCC with CSR02-Fab-TF
  • Saint Louis, Missouri
  • +6 more
Aug 16, 2022

US Selumetinib Registry

Not yet recruiting
  • Neurofibromatosis Type 1
  • Plexiform Neurofibromas
    • (no location specified)
    Jan 5, 2023

    Stage IV NSCLC Trial in Houston (Poly ICLC, IVIG)

    Not yet recruiting
    • Stage IV NSCLC
    • Houston, Texas
      Michael E. DeBakey VA Medical Center, Houston, TX
    Sep 28, 2023

    Hypophosphatasia Trial in Worldwide (ALXN1850, asfotase alfa)

    Not yet recruiting
    • Hypophosphatasia
    • Hartford, Connecticut
    • +29 more
    Oct 6, 2023

    Artificial Intelligence Evaluation of Fillings

    Completed
    • Dentomaxillofacial Radiology
    • Panoramic Radiography
    • Eskişehir, Turkey
      Eskişehir Osmangazi University
    Aug 31, 2023

    Solid Tumor Trial in Shanghai (DC cells)

    Recruiting
    • Solid Tumor
    • DC cells
    • Shanghai, Shanghai, China
      Shanghai Mengchao Cancer Hospital
    Aug 23, 2023

    Hypophosphatasia Trial in Worldwide (ALXN1850, Placebo)

    Not yet recruiting
    • Hypophosphatasia
    • Baltimore, Maryland
    • +39 more
    Oct 6, 2023

    Categories and Attaining LDL-C Targets in Middle Eastern Adults

    Not yet recruiting
    • Atherosclerotic Cardiovascular Risk
    • Low-density-lipoprotein (LDL) Cholesterol
      • (no location specified)
      Feb 16, 2023

      Myocardial Injury, ICU Trial in Guangzhou (Cardiopeptides)

      Recruiting
      • Myocardial Injury
      • ICU
      • Guangzhou, China
        Southern medical university Nanfang hospital
      Oct 31, 2023

      Mitral Splay Sign, Its Mechanism and Association With Severity

      Recruiting
      • Mitral Regurgitation
        • Tarusa, Kaluga Region, Russian Federation
          Tarusa Hospital
        Nov 29, 2023

        ATGAM General Investigation

        Not yet recruiting
        • Aplastic Anemia
        • Anti-human thymocyte immunoglobulin, equine
        • (no location specified)
        Sep 8, 2023

        Acute Myeloid Leukemia in Children Trial (Standard Intervention, Investigational Intervention)

        Not yet recruiting
        • Acute Myeloid Leukemia in Children
        • Standard Intervention
        • Investigational Intervention
        • (no location specified)
        Aug 8, 2023

        Booster Dose of Comirnaty in Children Ages 6 Months Though 4

        Not yet recruiting
        • SARS-CoV-2
        • COVID-19
        • COMIRNATY intramuscular injection
        • Tokyo, Japan
          Pfizer Local Country
        Nov 8, 2023

        BESPONSA Injection 1 mg Special Investigation

        Active, not recruiting
        • Acute Lymphocytic Leukemia
          • Tokyo, Japan
            Pfizer
          Jun 20, 2023

          Nociception Coma Scale-Revised With Personalized Stimulus

          Recruiting
          • Disorder of Consciousness
          • Nociception Coma Scale-Revised
          • Rome, Italy
            Rita Formisano
          Aug 24, 2023

          ive is Encorafenib Plus Binimetinib in Real-world and Clinical

          Not yet recruiting
          • Metastatic Melanoma
          • (no location specified)
          Jul 12, 2023

          Learn About Tafamidis in Transthyretin Amyloid Cardiomyopathy in

          Not yet recruiting
          • Transthyretin Amyloid Cardiomyopathy
          • (no location specified)
          Oct 11, 2023

          Rheumatoid Arthritis, Carpal Tunnel Syndrome Trial in Kirsehir (Angulus)

          Recruiting
          • Rheumatoid Arthritis
          • Carpal Tunnel Syndrome
          • Angulus
          • Kırşehir, Turkey
            Ahi Evran University
          Apr 6, 2023

          Neuromyelitis Optica Spectrum Disorder, NMOSD, AQP4+ NMOSD Trial

          Not yet recruiting
          • Neuromyelitis Optica Spectrum Disorder
          • +2 more
            • (no location specified)
            Jul 21, 2023

            Paroxysmal Nocturnal Hemoglobinuria Trial (Danicopan)

            Recruiting
            • Paroxysmal Nocturnal Hemoglobinuria
            • Baltimore, Maryland
            • +4 more
            Feb 1, 2023